Kerry “Gus” Hartauer is a senior director at Eli Lilly in the Lilly Research Laboratories. He joined Eli Lilly in 1989 as a research scientist and spent the first 12 years of his career in Formulation and Process Development. He subsequently moved into technical management roles within Lilly Research Laboratories having been a head of the Pharmacokinetics Department, and leading divisions of Formulation and Analytical Development. During his 23 year career at Eli Lilly, he has been an inventor on 8 issued U.S. Patents and several international patents.
In his tenure at Lilly in the laboratory, he led his formulation group in the development, scale‐up, and technology transfer of four unique, globally marketed drug products dosage forms that have been utilized in treating indications such as infectious diseases, osteoporosis, and depression. In his current role as senior director, CMC Project Management, he leads a group that provides CMC development leadership for all small molecules in the portfolio from candidate selection to launch.
Dr. Hartauer has published in journals such as Pharmaceutical Research, Drug Development and Industrial Pharmacy, International Journal of Pharmaceutics, Pharmaceutical Development & Technology, and AAPS Journal.
He received his Bachelor of Science in Pharmacy in 1984 from the University of Iowa and continued on at Iowa to earn his Doctorate in Pharmaceutical Sciences in 1989.